Company / Financials
10x Genomics, Inc. Financials
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$642.8M
FY2025 · +5.2% YoY
Net Income
-$43.5M
FY2025 · +76.2% YoY
Profit Margin
-6.8%
FY2025 · net income / revenue
ROE
-5.5%
FY2025 · return on equity
Total Assets
$1.0B
FY2025
Total Debt
-
FY2025
Equity
$796.3M
FY2025
ROA
-4.2%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$642.8M+5.2% YoYNet Income HistoryProfit after all expenses and taxes-$43.5M+76.2% YoYGross Profit HistoryRevenue minus cost of goods sold$443.9M+7.1% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$198.9M+1.3% YoYOperating Income HistoryProfit from core business operations before interest and taxes-$61.0M+68.7% YoYSG&A Expense HistorySelling, general, and administrative expenses$316.1M-8.2% YoYR&D Expense HistoryResearch and development spending$238.6M-9.8% YoYInterest Expense HistoryCost of borrowing and debt obligations-Income Tax HistoryTotal income tax expense$3.6M-26.2% YoYEPS (Basic) HistoryBasic earnings per share-$2.18-49.3% YoY